Skip to main content
. Author manuscript; available in PMC: 2014 Feb 21.
Published in final edited form as: Oncogene. 2013 Feb 25;33(8):1006–1016. doi: 10.1038/onc.2013.31

Table 3.

CD84 expression following MIF stimulation

patient age m/f zap70 doubling time (month) previous chemotherapy RAI stage autoimmune phenomena lymphocyte count (103/ml) serum IgG(mg/dl) Fold of CD84 (PCR) Fold of CD84 (FCS)
1 78 m negative 1 month FCR, L/P IV no 46 <700 1.71
2 56 f 6 month L/P I sjorgen 30 >700 1.3
3 74 m positive 6 month none II no 50 <700 1.97
4 53 m negative not reached FC/R IV yes 45 <700 2.8
5 72 f 6 month none 0 no 40 >700 1.33
6 60 m 6 month none 0 no 19 >700 2.53
7 80 f negative 12 month none 0/I no 140 <700 2.2
8 52 m positive 6 month none 0 no 12 >700 1.47
9 84 f 6 month none 0 no 42 >700 1.5
10 72 f 6 month none 0 no 40 >700 1.7
11 70 m negative 6 month none I no 15 >700 1.72
12 58 f positive not reached COP IV coombs pos150 >700 1.2
13 75 m negative not reached none 0 no 10 <700 2.36
14 59 f positive 3 month L/P II no 100 >700 2.6
15 72 m positive 2 month CHOP-likeIV IV no 80 <700 1.41
16 76 f positive 2 month CP, FC/R IV no 120 <700 1.6
17 72 f not reached none 0 no 40 >700 1.24
18 m positive 3 month FCR II no 40 <700 1.8
19 75 f positive 12 month none 0 no 40 <700 1.5
20 34 m negative none I no 40 >700 1.5
21 80 m positive 5 month COP, FCR IV no 6 <700 1.37
22 54 m positive 2 month FCR I no 30 >700 1.52
23 55 f nd 6 month 0 no 20 700 1.33